Chris Baxter is a founder of 6 professional services firms and a co-founder of 7 technology companies – all of which share one thing in common - they are highly innovative in their particular field. From his first part-time business partnership at the age of 22, Chris' driving passion has been and remains helping technology companies establish a firm intellectual property foundation and backing entrepreneurs with the connections they need to take innovative products to market.
In 2007, Chris founded Baxter IP Patent Attorneys. At that time, when Australian innovators approached patent attorney firms, what they would get was purely patent attorney services, a far cry from what was really required to help the entrepreneur succeed commercially. So, at the age of 25, after working for 2 large patent attorney firms and as an in-house patent attorney at ResMed Inc., Chris begun to formulate a business architecture where intellectual property attorney services were augmented by an ecosystem of commercial, development and capital service offerings, to give innovators much more than just intellectual property protection.
Chris is a Fellow of The Institute of Patent & Trade Mark Attorneys of Australia (IPTA) and a registered Australian and New Zealand patent attorney. Chris has a Masters Degree in Industrial Property from the University of Technology, Sydney during which he received the award for 1st place in Trade Mark Law and received 1st Class Honours and the Thesis Prize in Aeronautical Engineering at the University of Sydney. In 2019, Chris was awarded “Leading Specialist Patent and Trademark Attorney of the Year for Australia for 2019” by the Acquisition International Leading Advisers Awards.
Chris and Baxter IP enjoy a close working relationship with the UNSW Division of Enterprise. In 2019, Chris became a benefactor of the UNSW Founder’s Program making a significant donation to the Founder’s Fund to support the new Entrepreneur’s PhD Pathway Program. Baxter IP has been providing in-depth, pro-bono IP advice to their 10X and Health 10X cohorts since 2018.